Conference Coverage
Use of Fertility Preservation and Assisted Reproductive Technologies to Attempt Pregnancy Among Patients With Breast Cancer
01/04/2024
Hatem Azim, MD, PhD, Monterrey Institute of Technology, Nuevo León, Mexico discussed results from the POSITIVE trial which found that young age was the main factor associated with shorter time to pregnancy among patients with hormone receptor-positive breast cancer.
These results were first reported at the 2023 San Antonio Breast Cancer Symposium.
Source:
Azim H, Niman S, Partridge A, et al. Fertility preservation and assisted reproductive technologies (ART) in breast cancer (BC) patients (pts) interrupting endocrine therapy (ET) to attempt pregnancy. Presented at the 2023 San Antonio Breast Cancer Symposium; December 5-9; San Antonio, Texas. Abstract GS02-11